文献速递神经介入技术与安全DSA

介入放射学中的生物剂量学:基于皮肤的免疫检测用于预判皮炎风险

Biodosimetry in interventional radiology: cutaneous-based immunoassay for anticipating risks of dermatitis.
PubMed 文献 · Eur Radiol · 2021-03-31

本研究在95例神经介入患者中测试了新型体外生物剂量计DosiKit,该设备基于毛囊中辐射诱导的H2AX蛋白磷酸化与剂量的关系。对174份毛发样本定量检测显示,105份样本在介入术后出现γH2AX显著诱导;统计估计DosiKit免疫检测的阈值敏感度约为700 mGy。结论认为DosiKit可用于映射实际吸收剂量、识别介入放射学中的过量照射患者并预判皮炎风险。

要点

  • DosiKit通过毛囊γH2AX免疫检测估算皮肤实际吸收剂量。
  • 该检测阈值敏感度约700 mGy,可用于识别过量照射患者。
  • 在神经介入患者中验证,可辅助预判放射性皮炎风险。

核心结论

  • DosiKit可映射实际吸收剂量,识别介入放射学中过量照射患者,从而预判皮炎发生风险。

研究设计与样本

  • 前瞻性设备性能验证研究,在Clermont-Ferrand大学医院纳入95例接受神经放射介入治疗的患者。
  • 每个介入操作中,用氟化锂热释光剂量计(TLD)测量侧枕部头皮各毛发采集点的总剂量,并通过剂量归档与通信系统(DACS)收集常规间接剂量学参数。
  • 对辐射暴露前后的174份毛发样本进行辐射诱导H2AX蛋白磷酸化定量检测。

关键影像表现/征象

  • 174份毛发样本中,105份在放射学操作后显示γH2AX蛋白显著诱导。

诊断标准与关键数值

  • DosiKit免疫检测的阈值敏感度估计约为700 mGy。

临床应用与阅片要点

  • 在神经介入操作中,可采集侧枕部头皮毛发样本,利用γH2AX诱导程度映射皮肤实际吸收剂量。
  • 当检测提示剂量接近或超过700 mGy阈值时,应警惕患者存在过量照射及后续皮炎风险。

局限性

  • 研究仅纳入神经介入患者,样本量95例,结论外推至其他介入操作需谨慎。
  • 原文未报告敏感度、特异度、AUC等完整诊断性能指标。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Interventional radiology procedures expose individuals to ionizing radiation. However, existing dosimetry methods do not provide the dose effectively absorbed to the skin, and do not consider the patient's individual response to irradiation. To resolve this lack of dosimetry data, we developed a new external irradiation biodosimetry device, DosiKit, based on the dose-dependent relationship between irradiation dose and radiation-induced H2AX protein phosphorylation in hair follicles. This new biological method was tested in Clermont-Ferrand University Hospital to evaluate the assay performances in the medical field and to estimate DosiKit sensitivity threshold.

METHODS: DosiKit was tested over 95 patients treated with neuroradiological interventions. For each intervention, lithium fluoride thermoluminescent dosimeters (TLD) were used to measure total dose received at each hair collection point (lateral and occipital skull areas), and conventional indirect dosimetry parameters were collected with a Dosimetry Archiving and Communication System (DACS).

RESULTS: Quantitative measurement of radiation-induced H2AX protein phosphorylation was performed on 174 hair samples before and after the radiation exposure and 105 samples showed a notable induction of gammaH2AX protein after the radiological procedure. According to a statistical analysis, the threshold sensitivity of the DosiKit immunoassay was estimated around 700 mGy.

CONCLUSIONS: With this study, we showed that DosiKit provides a useful way for mapping the actually absorbed doses, allowing to identify patients overexposed in interventional radiology procedures, and thus for anticipating risk of developing dermatitis.

KEY POINTS: • DosiKit is a new external irradiation biodosimetry device, based on the dose-dependent relationship between irradiation dose and radiation-induced H2AX protein phosphorylation in hair follicles. • DosiKit was tested over 95 patients treated with neuroradiological interventions. • The threshold sensitivity of the DosiKit immunoassay was estimated around 700 mGy and DosiKit provides a useful way for mapping the actually absorbed doses.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Bensimon Etzol J, Rizzi Y, Gateau T, et al. Biodosimetry in interventional radiology: cutaneous-based immunoassay for anticipating risks of dermatitis. Eur Radiol. 2021. PMID: 33791818. doi:10.1007/s00330-021-07885-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。